Introduction
============

Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are voltage-gated channels encoded by the *HCN1-4* gene family. These channels are primarily expressed in the heart and in the central and peripheral nervous systems ([@B95], [@B96]; [@B108]). HCN channels conduct K^+^ and Na^+^ ions at a ratio of 3:1 to 5:1. They are activated by hyperpolarization of membrane voltage to -50 mV or below, and conduct the hyperpolarization-activated current, termed *I*~f~ in heart and *I*~h~ in neurons ([@B20]; [@B36]; [@B83]; [@B119]). cAMP can regulate the voltage-dependent activation of HCN channels in a subtype-specific manner, with HCN2 and HCN4 channels being highly susceptible to this molecule ([@B62]). Downregulation of cAMP suppresses *I*~h~ and shifts the HCN activation curve to lower voltage values ([@B13]). HCN channels play essential roles in the modulation of neuronal excitability, rhythmic neuronal activity, dendritic integration, and synaptic transmission, thus mediate multiple physiological functions. For example, HCN channels are able to regulate sleep and wakefulness ([@B70]; [@B144]), learning and memory ([@B107]; [@B106]), and somatic sensation ([@B41]; [@B37]). Indeed, dysfunction of HCN channels is closely associated with several pathophysiological states, including epilepsy ([@B35]; [@B100]), neuropathic pain ([@B42]; [@B132]), and inflammatory pain ([@B42]; [@B127]). Recent studies have also shown that HCN channels play a significant but complex role in neurodegenerative diseases.

Neurodegenerative diseases are chronic, progressive, and age-associated disorders, characterized by selective loss of neurons in specific brain regions. As the global population increases, the incidence of these diseases increases accordingly, and thus neurodegenerative diseases have become a serious public health issue. Nevertheless, their etiology and pathogenesis have not yet been fully elucidated, which hinders the identification of key therapeutics, and the evaluation of their potential application as therapeutic. The pathogenesis of neurological disease is closely associated with the dysfunction of neuronal excitability, rhythmicity, and signaling, which are generated and modulated by specific sets of proteins, including ion channels. HCN channels are widely expressed in the basal ganglia and hippocampus, where they control the electrical activities of substantia nigra pars compacta (SNc) dopaminergic neurons and hippocampal glutamatergic neurons ([@B111]; [@B125]). In agreement with these findings, HCN channel dysfunction has been implicated in PD and AD ([@B23]; [@B117]). Changes of HCN channels are also observed in ALS and SMA ([@B78]; [@B123]). Therefore, in this review, we focus on the roles of HCN channels in the pathogenesis of PD, AD, and other neurodegenerative diseases. We also discuss whether modulation of these channels could provide a new therapeutic target for the alleviation of symptoms related to these neurodegenerative diseases.

HCN Channels and PD
===================

Parkinson's disease is the second most common neurodegenerative disorder, characterized by a progressive degeneration of dopaminergic neurons in the SNc. PD patients often suffer from an array of motor impairments, including rigidity, resting tremor, postural instability, and bradykinesia. Non-motor symptoms such as olfactory loss, anxiety and depression, sleep abnormalities, and constipation are also present during early stages of the disease ([@B124]; [@B138]; [@B15]; [@B112]; [@B33]). Dopaminergic neurons in SNc send neurological projections to several brain regions and help to chemically differentiate the direct and indirect pathways. Previous reports have shown that HCN channels are widely expressed in multiple basal ganglia such as the SNc, the globus pallidus (GP), and the STN. Moreover, HCN channels are involved in the regulation of electrical activities of these neurons under physiological and pathological conditions ([@B118]; [@B96]). To date, studies on HCN channels and PD have mainly focused on the following aspects: (1) alteration of HCN channel expression and function in PD animal models, (2) potential involvement of HCN channels in the neurotoxic effects of MPP^+^, and (3) HCN channels as a mechanism for the selective vulnerability of SNc neurons. Given current reports of the critical role of HCN channels in neuroinflammation and depression, we also discuss their possible involvement in the inflammatory processes and non-motor symptoms of PD.

HCN Channels Regulate the Electrical Activities of Neurons in the Basal Ganglia
===============================================================================

In the 1980s, *I*~h~ was first recorded in SNc dopaminergic neurons ([@B76], [@B77]). The current was observed to become slowly activated at approximately -70 mV and was fully activated at -129 to -140 mV ([@B77]; [@B91]). The current was specifically blocked by ZD7288 within a specific concentration range (\<100 μM) ([@B61]; [@B121]; [@B102]). Later, mRNA expression of HCN2--HCN4 was examined in SNc dopaminergic neurons using single-cell RT-mPCR and *in situ* hybridization ([@B48]; [@B118]), showing that both HCN2 and HCN4 are expressed at relatively higher levels than HCN3 ([@B91]; [@B48]; [@B53]). Under current-clamp conditions, dopaminergic neurons exhibit a pronounced rebound depolarization (sag) mediated by *I*~h~ in response to a series of hyperpolarizing current pulses. The presence of *I*~h~ or sag has been used as a key criterion for the identification of dopaminergic neurons ([@B56]). In these neurons, *I*~h~ has a high density of expression around the axon-bearing dendrites, and is reduced with distance from the axon origin, which may affect synaptic integration ([@B43]). [@B102] further reported that there were significant differences in HCN channel density in various subpopulations of dopaminergic neurons. Calbindin-negative SNc dopaminergic neurons, which were more vulnerable to neurotoxins, possessed a larger sag amplitude and *I*~h~ density than calbindin-positive neurons ([@B102]). Neurons in the GP also respond to series of hyperpolarizing current pulses with a drop in current (sag). Studies have shown that HCN1--4 channels are expressed in the GP and STN. Among them, HCN2 is the major isoform in the GP ([@B25]), while HCN2 and HCN3 are more highly expressed in the STN ([@B3]).

HCN channels have been reported to regulate the electrical activities of neurons in basal ganglia. SNc dopaminergic neurons display two predominant types of firing patterns *in vivo*: tonic irregular single-spike activity and phasic burst activity. *In vitro*, they only exhibit slow and regular spontaneous firing activity. The spontaneous firing activity of dopaminergic neurons was significantly inhibited after application of the HCN channels blocker ZD7288 (\<100 μM) in acutely prepared mouse or rat midbrain slices ([@B121]; [@B102]; [@B111]). [@B24] further observed that ZD7288 (50 μM) inhibited spontaneous firing activity in juvenile wild-type SNc dopaminergic neurons (less than postnatal 21 days), and was able to completely block firing in adult Cav1.3^-/-^ SNc dopaminergic neurons. Pharmacological blockade of HCN channels also promoted burst firing in SNc dopaminergic neurons of mice, which led to the release of a large amount of dopamine ([@B97]).

HCN channels also make an important contribution to the autonomous pacemaking in GP neurons ([@B25]; [@B130]). Application of ZD7288 (50 μM) or Cs^+^ in acutely prepared mouse brain slices led to hyperpolarization and reduced firing rate and regularity ([@B25]). Subsequently, a novel computational model of GPe neurons confirmed that when HCN channels were blocked, the pacemaker activity of GPe neurons was reduced or abolished ([@B92]). However, HCN channels could regulate firing of GP neurons bidirectionally *in vivo* ([@B26]). Using single-unit extracellular recordings, Chen et al. observed that micro-pressure ejection of ZD7288 and Cs^+^ decreased the frequency of spontaneous firing in 21 out of 40 GP neurons recorded, but increased the firing rate in another 18 neurons. Similar results were obtained when using 8-Br-cAMP, an activator of HCN channels ([@B26]). Since GP neurons consist of two types of neurons, GP-TI and GP-TA ([@B86]), the bidirectional modulation of HCN channel firing activity may be a result of the interplay between these two types of neurons. As for the effect of HCN channels on pacemaking activity in the STN neurons, previous articles have reported that the effect was negligible in rat brain slices ([@B11]; [@B38]). However, [@B34] revealed that HCN channels could bidirectionally regulate the firing of STN neurons *in vivo* by using single-unit extracellular recordings, which was similar to their previously published report in the GP.

HCN channels also regulate the oscillatory activity of basal ganglia neurons. Oscillation activities, mainly including alpha (8--12 Hz), beta (11--30 Hz), delta (1--3 Hz), and theta (2--7 Hz)-frequency bands, are prominent features of the neuronal network and are closely related to many brain behavioral and functional states ([@B67]). Theta activity has been reported to lead to a paroxysmal increase in freezing behavior in PD patients ([@B47]; [@B64]). HCN channels reportedly contribute to theta frequency membrane resonance in hyperpolarized mammalian SNc neurons, which may be involved in theta oscillation ([@B140]). This membrane resonance in the hyperpolarized potential ranging from -60 to -80 mV was completely abolished by application of ZD7288 (10 μM) ([@B140]). In the late stage PD, excessive synchronized oscillation and high-frequency bursts often occur in STN neurons ([@B110]; [@B10]; [@B131]). A recent study showed that the resonance in rat STN was also mediated by HCN channels, and application of ZD7288 (20 μM) could abolish it ([@B141]).

Alteration of HCN Channel Expression and Function in PD Animal Models
=====================================================================

Functional changes in HCN channels within the basal ganglia have been observed in several animal models of PD. Previous studies have shown a progressive downregulation of HCN channels in SNc neurons in MitoPark mice ([@B54]), a transgenic model in which a mitochondrial mutation caused parkinsonism ([@B40]). MitoPark mice exhibited reduced current amplitude and a more negative *I*~h~ activation curve at postnatal 7--8 weeks, whereas motor dysfunction was not observed until 12 weeks. Therefore, HCN channel downregulation in SNc dopaminergic neurons may be one of the earliest physiological changes related to PD in MitoPark mice ([@B54]). The finding that functional changes occur in SNc dopaminergic neurons prior to the onset of distinct behavioral symptoms in animal models of PD and Parkinsonian patients suggests that *I*~h~ could play an important role in the early stages of disease. Consistent with the above results, reduced *I*~h~ amplitude and density were recently observed in SNc dopaminergic neurons in spontaneous α-synuclein overexpressing rats ([@B59]).

The amplitude of *I*~h~ in GP neurons was also significantly reduced in acute reserpine-treated mice ([@B23]). Similar results were obtained in mice and rats as a result of chronic injection of 6-OHDA, a classic neurotoxin that causes PD ([@B23]). In all of these models, the downregulation of HCN channel expression/activity contributed to the progressive decline in the autonomous pacemaker activity of GPe neurons. They further demonstrated that the protein and mRNA levels of the four HCN subunits were reduced in the GPe, with HCN2 being the most affected. Moreover, dopamine depletion induced a significant reduction in tetratricopeptide repeat-containing TRIP8b mRNA. TRIP8b, a brain-specific cytoplasmic protein and an HCN channel auxiliary subunit in the mammalian brain, influences HCN channel surface expression and regulates their gating and kinetics ([@B145]; [@B4]). Thus, these results suggested that both transcriptional and trafficking-related mechanisms may be involved in the downregulation of HCN channels, producing a progressive loss of autonomous pacemaking in GPe neurons and exacerbating their rhythmic bursting ([@B23]).

[@B93] also studied the role of HCN channels in the GPi. They demonstrated that HCN3 mRNA was selectively upregulated by twofold in the entopeduncular nucleus/GPi of rats and mice with 6-OHDA-induced parkinsonism. In agreement with this change in mRNA expression, both HCN3 current amplitude and neuronal excitability were significantly increased in the lesioned animals ([@B93]). These data indicated a potential association of HCN channels with altered excitability of basal ganglia output neurons in PD. In addition, the role of HCN channels in the GP may depend on the subtype and distribution environment of the channels.

Potential Involvement of HCN Channels in the Neurotoxic Effects of MPP^+^
=========================================================================

MPP^+^ is a traditional neurotoxin that can induce Parkinsonian syndrome in experimental primates and rodents. It is converted from the pro-toxin MPTP to MPP^+^ and then selectively uptaken by SNc dopaminergic neurons through the DAT. Once inside the cell, MPP^+^ primarily inhibits mitochondrial complex I, leading to ATP depletion, oxidative stress, and eventual cell death ([@B103]; [@B126]; [@B66]). In addition to the classical mitochondrial impairment mechanism, several studies have also described the effects of MPP^+^ on neuronal electrophysiological activities. Acute application of MPP^+^ on midbrain slices led to hyperpolarization of SNc dopaminergic neurons and reduced their firing rate ([@B81]; [@B87]; [@B142]). However, the ionic mechanisms of this toxin on neuronal electrophysiological properties remain controversial. Previous work has attributed the effects of MPP^+^ to the opening of ATP-sensitive potassium (K-ATP) channels, which is supported by the observation that MPP^+^ caused mitochondrial failure and ATP depletion ([@B81]). Subsequently, [@B87] demonstrated that MPP^+^ still led to a rapid hyperpolarization along with a reduction in spontaneous firing activity, even after preincubation with the K-ATP channel blocker glybenclamide. They further proposed that the effects of MPP^+^ were mediated by HCN channels ([@B87]), specifically that MPP^+^ inhibited *I*~h~, shifted the *I*~h~ activation curve toward negative potentials, and slowed the *I*~h~ activation kinetics. These effects occurred under K-ATP channel blockade and in the presence of 2 mM ATP, indicating that it was independent of mitochondrial mechanisms. Thus, they speculated that MPP^+^ may directly interact with HCN channels ([@B87]). However, [@B142] reported that MPP^+^ inhibited the activity of dopaminergic neurons in distinct stages through different mechanisms. The early phase of inhibition was dependent on D2 autoreceptors, whereas the late phase was due to the activation of K-ATP channels. Although *I*~h~ was reduced by MPP^+^ in their study, pharmacological blockade of HCN channels did not prevent the inhibitory effects of MPP^+^. Thus, the inhibition of *I*~h~ by MPP^+^ may promote hyperpolarization through activation of some channels, such as K-ATP channels ([@B142]).

In summary, current literature indicates that MPP^+^ has acute inhibitory actions on nigral dopaminergic neurons. Although independent groups have explored ionic mechanisms in this context, results remain controversial. One should note that these studies used inconsistent concentrations of MPP^+^ (range from 10 to 50 μM), electrophysiological recording methods, and drug administration methods. Further studies are required to assess the impact of HCN channels on the neurotoxicity of MPP^+^.

HCN Channels May Be an Ion Channel Mechanism Underlying the Selective Vulnerability of SNc Neurons
==================================================================================================

A hallmark of PD is the selective vulnerability of SNc dopaminergic neurons to damage and cell death and is contrasted with the relative resistance of dopaminergic neurons in the neighboring VTA to the disease ([@B40]; [@B14]; [@B19]). However, the mechanisms underlying this selective vulnerability remain unclear. The genetic profile of these regions only differs by 1--3% ([@B57]), indicating that the genetic factors may not account for this discrepancy. Recent research has begun to explore the role of electrophysiological determinants, proposing that specific types of ion channels, including HCN channels, may be the basis for this selective vulnerability ([Table 1](#T1){ref-type="table"}) ([@B39]).

###### 

Comparison of electrophysiological parameters of dopaminergic neurons in the SNc and VTA.

  Electrophysiological parameters   SNc (![](fnmol-12-00141-i001.jpg) ± SEM)                          VTA (![](fnmol-12-00141-i001.jpg) ± SEM)   Selected references
  --------------------------------- ----------------------------------------------------------------- ------------------------------------------ ---------------------
  Body size (μm^2^)                 176.29 ± 5.84                                                     113.18 ± 3.57                              [@B75]
  Rm (MΩ)                             227 ± 10                                                          697 ± 99                                 [@B75]
  Cm (pF)                             57 ± 2                                                            44 ± 4                                   [@B75]
  Sag (mV)                              37.3 ± 0.72                                                       31.0 ± 1.72                            [@B102]
  *I*~h~ (pA)                         299 ± 14                                                          45 ± 9                                   [@B75]
  Firing frequency (Hz)                 2.1 ± 0.2                                                         1.5 ± 0.1                              [@B139]
                                    Significantly inhibited after pharmacologically blocking *I*~h~   Negligible                                 [@B102]; [@B75]
  EPSP                              Obviously enhanced after pharmacologically blocking *I*~h~        Negligible                                 [@B87]
  IPSP                              Significantly inhibited after pharmacologically blocking *I*~h~   Negligible                                 [@B87]
  SCR                               Remarkably activated after pharmacologically blocking *I*~h~      Negligible                                 [@B22]
                                                                                                                                                 

Rm, membrane resistance; Cm, capacitance values; EPSP, excitatory post-synaptic potential; IPSP, inhibitory post-synaptic potential; SCR, somatic calcium response.

Compared to VTA dopaminergic neurons, SNc neurons exhibit a larger cell body size, lower Rm, higher Cm ([@B75]), faster firing frequency ([@B139]; [@B75]), and a distinct sag in response to a series of hyperpolarizing current pulses ([@B102]), which appeared to correlate with the larger *I*~h~ magnitude. Indeed, the distribution of HCN channels in midbrain dopaminergic neurons is consistent with a ventro-dorsal gradient. In other words, SNc neurons show a larger average *I*~h~ than VTA neurons ([@B75]). Moreover, there is a higher percentage of *I*~h~-negative dopaminergic neurons in the VTA ([@B88]). The *I*~h~ blocker ZD7288 (\<100 μM) inhibited firing activity in the SNc, but this effect was negligible in the VTA of both mice and rats ([@B102]; [@B71]; [@B75]). It is worth noting that unilateral ZD7288 injection into the SNc of adult rats prominently increased the number of apomorphine-induced rotations and reduced the immunofluorescence intensity of tyrosine hydroxylase-positive neurons. These effects were not observed in VTA neurons ([@B22]).

Notably, *I*~h~ differentially regulates the responsiveness to excitatory synaptic inputs in SNc and VTA neurons. MPP^+^ increased the temporal summation of evoked eEPSPs in SNc neurons *via* the inhibition of *I*~h~ ([@B87]). Direct pharmacological suppression of *I*~h~ through ZD7288 (50 μM) also increased the decay time and amplitude of eEPSPs, and this response was more prominent in SNc than in VTA neurons ([@B88]). ZD7288 also significantly reduced the amplitude of evoked inhibitory post-synaptic potentials (eIPSPs) ([@B22]). Therefore, *I*~h~ blockage likely enhances synaptic excitability through a dual mechanism in SNc dopaminergic neurons, specifically, by potentiating excitatory inputs and weakening inhibitory inputs. More importantly, increased excitatory synaptic transmission led to the amplification of SCRs in SNc neurons, while this response was minimally affected in VTA neurons ([@B22]). In addition, low intracellular ATP caused a significant negative shift in the *I*~h~ activation curve ([@B22]), suggesting that *I*~h~ dysfunction may be linked to the mechanisms that trigger PD, such as mitochondrial failure and ATP depletion, and that *I*~h~ dysfunction may act in concert with SNc-specific synaptic connectivity to promote selective vulnerability ([@B88]).

Based on the evidence mentioned above, we proposed a model of the pathogenic cascade in SNc neurons during PD progression ([Figure 1](#F1){ref-type="fig"}): with the participation of a causative agent, mitochondrial dysfunction results in a decrease in intracellular ATP levels, which in turn inhibits ATP-dependent *I*~h~. MPP^+^ may also directly interact with HCN channels, causing the inhibition of *I*~h~, and thus reducing spontaneous firing. This leads to the amplification of SCRs by potentiating EPSP and depressing IPSP, which ultimately results in an imbalance of intracellular calcium homeostasis and selective degeneration of SNc dopaminergic neurons.

![Hypothetical HCN channel-related pathogenic cascade in SNc dopaminergic neurons in PD. **(A)** HCN channels modulate the electrophysiological activities of SNc dopaminergic neurons. Dopaminergic neurons display tonic irregular single-spike firing and phasic burst firing *in vivo*, and slow, regular, pacemaker activity *in vitro*. HCN channels blockade with ZD7288 reduces the amplitude of *I*~h~, leading to cell membrane hyperpolarization, decreased firing activity, or even increased burst firing *in vitro*. HCN channels also regulate neuronal oscillatory activity. **(B)** Proposed mechanism for the involvement of HCN channels in the neurotoxic effects of MPP^+^. MPP^+^ accumulates in mitochondria, where it inhibits complex I, causing ATP depletion, increased ROS formation, and oxidative stress. The decreased cellular ATP and cAMP concentration leads to the opening of K-ATP channels and inhibition of HCN channels. This results in hyperpolarization of the cell membrane and reduction in the spontaneous firing of dopaminergic neurons. MPP^+^ is also speculated to directly interact with HCN channels, causing *I*~h~ inhibition. This further leads to the amplification of SCRs by potentiating EPSP and depressing IPSP, which results in an imbalance of intracellular calcium homeostasis. This in turn potentiates oxidative stress and ultimately leads to cell death.](fnmol-12-00141-g001){#F1}

Importantly, some of the above results, such as the ability of *I*~h~ to affect EPSP and EPSP-driven SCRs, were obtained using the channel blocker ZD7288. It has previously been suggested that ZD7288 induced a *I*~h~-independent reduction of synaptic transmission in hippocampal neurons ([@B136]), but this phenomenon has not been reported in SNc and VTA neurons. Therefore, the mechanism of action of ZD7288 in SNc synaptic transmission requires further verification to support our hypothesis.

Putative Contribution of HCN Channels to Inflammatory Processes in PD
=====================================================================

A common hallmark of neurodegenerative diseases is the presence of neuroinflammation ([@B58]; [@B113]; [@B32]; [@B82]). Reactive microglia, which is the main glial cell type that participates in the inflammatory response in the brain, was first revealed in the SNc of postmortem human brain tissue as early as in 1988 ([@B90]). Elevated cytokine IL-1β and TNF-α were detected in the SNc and striatum of PD patients and animal models ([@B99]; [@B5]). Activated microglial cells secrete pro-inflammatory cytokines and produce ROS, and these inflammatory factors in turn induce the activation of astrocytes, which could not promote neuronal synapse formation, but rather released toxic factors that caused neuronal damage ([@B31]; [@B45]).

Neuroinflammation has been reported to target specific sets of channel proteins, including HCN channels. To date, there is no report that relates the possible role of HCN channels to PD-related neuroinflammation. However, in non-PD-related brain regions, *in vivo* elevation of type I IFNs by viral brain infection or acutely applied recombinant type I IFNs to rat slices has been shown to reduce HCN1-mediated *I*~h~ in cortical pyramidal neurons ([@B127]). More importantly, IFN-β hyperpolarized the cell membrane, reduced neuronal resonance, and modulated spontaneous EEG slow-wave activity depending on the presence of HCN1 and reversibly altered the physiological responses of cortical neuronal networks ([@B127]). Similarly, a recent study by Federica and colleagues showed that bilateral stereotactic injection of LPS into rats' lateral ventricles could reduce HCN1 and TRIP8b protein levels, as well as *I*~h~ amplitude and kinetics in CA1 pyramidal neurons ([@B51]). Moreover, LPS treatment hyperpolarized the resting membrane potential, increased the input resistance, reduced resonance properties, and increased temporal summation of synaptic inputs, which was consistent with the inhibition of *I*~h~. These data indicated that neuroinflammation can modulate the electrophysiological properties of neurons by affecting HCN channels and the related *I*~h~ current. Given the critical role of HCN channels in neuroinflammation, we boldly speculate that HCN channels could be involved in the progression of PD and even other neurodegenerative diseases *via* neuroinflammatory regulation.

Putative Contribution of HCN Channels to the Non-Motor Symptoms in PD
=====================================================================

Patients with PD are usually accompanied by numerous non-motor symptoms, such as depression, olfactory loss, sleep abnormalities, and constipation. To date, no studies are available concerning the possible impact of HCN channels on the non-motor symptoms of PD. However, growing evidence suggests that HCN channels and their auxiliary subunit TRIP8b play an important role in the action of antidepressant and depression. Mice with reduced *I*~h~ in the hippocampal CA1 region resulting from whole-brain deletion of TRIP8b, HCN1, or HCN2 all demonstrated significant resistance to multiple tests of behavioral despair with high predictive validity for antidepressant efficacy ([@B79]). In TRIP8b knockout mice, restoring TRIP8b expression in the dorsal CA1 region enhanced HCN protein expression and reversed the antidepressant-like behaviors ([@B60]; [@B85]). [@B73] further observed that rats infused with lentiviral shRNA-HCN1 in the dorsal hippocampal CA1 region displayed antidepressant- and anxiolytic-like behaviors associated with widespread enhancement of hippocampal activity. Similar result was also confirmed in CUS, a widely accepted model for major depressive disorder. Deletion of HCN1 by shRNA-HCN1 in the dorsal CA1 region prevented the CUS-induced behavioral deficits ([@B72]).

Multiple lines of evidence implicate dysregulation in the brain's reward neural circuit in depression. Dysfunction of the dopamine reward system is thought to contribute to a hedonia and the loss of motivation common in depression ([@B9]; [@B101]; [@B134]). *I*~h~ has also been reported to be increased in dopaminergic neurons of VTA in mice under CSDS, a well-established rodent model of depression ([@B21]; [@B50]). However, *I*~h~ has been noted to be decreased in dopaminergic neurons of VTA in CMS, which is also a widely used depression model. A knockdown of HCN2 by lentiviral shRNA-HCN2 shRNA in the VTA produced depressive- and anxiety-like behavior, and overexpression of HCN2 in the VTA prevented the development of CMS-induced depressive-like behavior ([@B143]). Thus, different HCN isoforms in different brain regions may play distinct roles in regulating depressive behavior.

In addition to the possible role of HCN channels and their auxiliary subunit in depression-like behavior, a possible link between HCN channels and the olfactory, sleep, and gastrointestinal functions in animal models is also noteworthy ([@B129]; [@B49]; [@B1]; [@B137]; [@B122]; [@B65]; [@B46]). Because of the important diagnostic and therapeutic value of these non-motor symptoms in PD, perhaps the above studies provide a new perspective for further exploration of PD.

HCN Channels and AD
===================

Alzheimer's disease is the most common neurodegenerative disease and is characterized by neuropsychiatric symptoms such as progressive memory impairment, cognitive dysfunction, personality changes, and language disorders, which seriously affect the patient's quality of life ([@B55]). The accumulation of the β-amyloid peptide (Aβ) within the brain and hyperphosphorylated and cleaved forms of the microtubule-associated protein tau are two key pathological features of AD ([@B109]). Lesions caused by the accumulation of these proteins mainly affect the hippocampus, the associative cortices, and subcortical structures ([@B17]). HCN channels are widely distributed in these regions and may participate in the etiology of AD by affecting neuronal excitability and regulating Aβ generation ([@B28]; [@B117]).

The Relationship Between HCN Channels and Age
=============================================

Changes in HCN channels in AD-associated brain regions are closely related to age. [@B135] published a pioneering study investigating the postnatal development of *I*~h~ in mouse hippocampal pyramidal neurons. Both *I*~h~ amplitude and HCN channels immunoreactivity appeared to increase with age from postnatal 1 to 20 days in CA1 and CA3 hippocampal pyramidal neurons. In addition, *I*~h~ activation became progressively more rapid over the 1- to 20-day interval ([@B135]). Subcellular HCN channel distribution also varied with age. HCN1 expression was found in the dendrites of rat hippocampal pyramidal neurons 2 days after birth and remained the only subtype present in dendrites until 2 weeks after birth. HCN2 was clearly distributed in the neuronal soma of rat hippocampal pyramidal neurons neonatally and was detected in the dendrites of hippocampal pyramidal neurons from the third week ([@B18]; [@B6]). As rat CA1 pyramidal neurons matured, HCN1 expression prominently increased, becoming the primary HCN channel subtype ([@B18]). This information suggests that the different expression patterns of HCN channels and *I*~h~ between immature and mature neurons may promote changes in neuronal excitability, which affect neuronal physiology and possibly lead to a pathological state.

HCN1 levels have been described to decrease dramatically in the temporal lobe of cynomolgus monkeys during aging, and be also significantly diminished in the temporal lobe of sporadic AD patients ([@B117]). The latest evidence demonstrated that the HCN1l and its auxiliary subunit, TRIP8b, were distally enriched in CA1 pyramidal neurons in both WT and 1-month-old ADTg mice but absent in ADTg mice at 12 and 24 months. The neuronal sag and rebound slope, as subthreshold voltage signatures, changed and deteriorated with age ([@B98]), and trafficking the HCN1 channel to distant dendrites restored abnormal subthreshold voltage signaling.

Role of HCN Channels in the Regulation of Aβ Generation
=======================================================

Aβ is the main component of senile plaques, and its deposition may be a common pathway for all causative factors leading to AD. Aβ is generated by sequential cleavage of the transmembrane amyloid-β precursor protein (APP) by β-secretase and the γ-secretase complex. γ-secretase may cleave at either of two sites, forming two different lengths of Aβ including Aβ40 and the more neurotoxic Aβ42 ([@B120]; [@B109]). An increase in neuronal activity could enhance the production of Aβ ([@B69]; [@B28], [@B27]). Given the critical role of HCN channels in neuronal excitability, correlations between HCN channels and Aβ generation have long been suspected. Recent findings showed enhanced Aβ generation in entorhinal cortex after blockade of HCN1, as well as in global HCN1^-/-^ mice. In contrast, overexpression of HCN1 in Neuro2a cells decreased Aβ generation, whereas inhibition of the overexpressed HCN1 channel activity restored the level of Aβ production ([@B117]). HCN1^-/-^ mice had a significantly higher resting membrane potential and input resistance measured from responses to either negative or positive current steps, indicating that loss of the HCN1 subunit enhanced neuronal excitability in entorhinal cortex ([@B105]). Thus, HCN1 may be involved in Aβ generation by regulating neuronal excitability. [@B44] further observed that rats with injection of Aβ peptides into the frontal cortex exhibited decreased excitability in hippocampal pyramidal neurons, which was caused by upregulation of *I*~h~ mediated *via* increased HCN1 mRNA.

In addition to relying on alterations in neuronal excitability, HCN1-mediated Aβ generation was also influenced by X11. The latter is an adaptor protein which binds to HCN channels and regulates the trafficking and metabolism of APP ([@B16]; [@B63]; [@B74]; [@B114]). Saito et al. found that *I*~h~ amplitude and density decreased sharply in the entorhinal cortex of mice lacking both X11- and X11L. Together with X11 and X11L, APP and HCN1 were co-immunoprecipitated from the entorhinal cortex. Therefore, HCN1 may form a complex with APP and X11 or X11L to regulate the generation of Aβ ([@B117]).

As a γ-secretase-associated protein, the HCN2 channel could also participate in the regulation of Aβ production. Silencing HCN2 in HEK cells overexpressing wild-type APP (HEK-APP cells) led to a prominent decrease in Aβ40 and Aβ42, as well as a reduction in α-secretase and β-secretase cleavage. In addition, while the FL-APP levels did not change significantly, its glycosylation decreased in HEK-APP cells after silencing of HCN2 ([@B52]). Thus, HCN2 could affect APP maturation by modulating the glycosylation of APP. Previous work has shown that glycosylated APP was reduced in Neuro2a cells overexpressing X11L ([@B116]). Interestingly, the HCN2 channel formed a complex with X11L in rat brain and in a heterologous expression cell system ([@B74]). Thus, HCN2 may also regulate the generation of Aβ by forming a complex with X11L ([Figure 2](#F2){ref-type="fig"}).

![Possible role of HCN channels in the generation of Aβ. Aβ is produced by two proteolytic enzymes, β- and γ-secretase. Downregulation of HCN1 channel could enhance the production of Aβ by increasing neuronal excitability in entorhinal cortex. Rats with injection of Aβ peptides into the frontal cortex exhibited decreased excitability in hippocampal pyramidal neurons, which was caused by upregulation of *I*~h~ mediated *via* increased HCN1. In addition, both HCN1 and HCN2 channels were able to form a complex with X11 or X11L proteins to regulate Aβ generation. The HCN2 channel can also participate in the regulation of Aβ production as a γ-secretase-associated protein, and by affecting APP maturation *via* modulation of the glycosylation of APP.](fnmol-12-00141-g002){#F2}

Role of HCN Channels in Learning and Memory of Relevance to AD
==============================================================

Progressive learning and memory impairment is a major clinical symptom of AD. These changes have been primarily linked to dysregulated Ca^2+^ signaling ([@B12]; [@B7], [@B8]). Previous work has shown that high HCN1 expression may interfere with the generation of Ca^2+^ spikes in hippocampal CA1 pyramidal neurons ([@B133]). In hippocampal pyramidal neurons from HCN1^-/-^ mice, the amplitude and duration of distal dendritic Ca^2+^ events have been found to be enhanced. This has also been observed after a blockade of HCN channels with ZD7288 (10 μM). This effect was attributed to a reduction in *I*~h~, which resulted in resting membrane hyperactivation and increased input resistance ([@B133]). This resembles the previously mentioned amplification of SCRs induced by blockade of *I*~h~ in the SNc ([@B22]).

The role of HCN channels in learning and memory has also been examined directly in gene knockout mice ([@B107], [@B106]; [@B89]; [@B128]). Nolan et al. first explored the role of HCN1 in motor learning and memory. Global HCN1^-/-^ mice showed remarkable deficits in motor learning and memory, whereas those with HCN1^f/f,cre^ did not have this deficit. These defects in motor learning and memory were hypothesized to result from the loss of HCN1 in cerebellar Purkinje cells, a key component of the cerebellar circuit ([@B107]). Although the HCN1 did not participate in the spontaneous discharge activity of Purkinje cells, HCN1 stabilizes the integration characteristics of Purkinje cells by mediating the depolarizing inward current that counteracts hyperpolarizing inputs which would otherwise push the membrane potential below the threshold for spontaneous spiking. This mechanism would allow Purkinje cells to maintain a constant input--output relationship independently of the effects of previous inputs to the cerebellum ([@B107]).

Later, [@B106] investigated the role of HCN1 in spatial learning and memory. In contrast to the results mentioned above, they found that HCN1^-/-^ mice had enhanced spatial learning and memory ([@B106]). Theta activity, which plays an important role in coding and storing spatial information, was selectively enhanced in hippocampal CA1 pyramidal neurons both in HCN1^-/-^ and HCN1^f/f,cre^ mice. Moreover, deletion of HCN1 from forebrain neurons enhanced hippocampal-dependent learning and memory, as well as LTP at the direct perforant path input to the distal dendrites of CA1 pyramidal neurons ([@B106]). These results demonstrate that the same ion channel may have distinct functional roles in different forms of learning and memory, depending on the cell environment and the neuronal circuitry in which the channel is involved.

[@B89] further found that LTP was significantly increased in the perforant path of HCN2^-/-^ mice. In contrast to HCN1^f/f,cre^ mice, LTP was not enhanced in mice with HCN2 selectively knocked out in hippocampal pyramidal neurons (HCN2^PyrKO^). Assessment of the amplitude and frequency of spontaneous inhibitory postsynaptic potentials (sIPSP) showed that the inhibitory interneurons were damaged in HCN2^-/-^ mice. LTP was remarkably enhanced when HCN2 was deleted from interneurons ([@B89]). Therefore, HCN2 appears to act on inhibitory interneurons in the hippocampal CA1 area to regulate LTP.

Interestingly, recent experimental results showed that global HCN3^-/-^ mice had no significant motor or spatial learning deficits in comparison with control mice ([@B128]), suggesting that different subtypes of HCN channels may play different roles in learning and memory.

Notably, in an AD-related CCH animal model, HCN channels were also reported to be involved in spatial learning and memory ([@B80]; [@B84]). CCH can promote learning and memory impairment and is a common risk factor for AD ([@B29], [@B30]; [@B68]). Rats with 2VO also developed stable and long-term impairment of spatial learning and memory. [@B84] found that rats, in the progressive phase of CCH, showed differentially altered HCN1 and HCN2 in the rat hippocampal CA1 region, and the HCN2/HCN1ratio increased throughout the process of chronic hypoperfusion. Specifically, the expression of HCN1 surface subunits was decreased at 4 weeks of 2VO, but exhibited no significant change at 8 or 12 weeks. In contrast to HCN1, HCN2 surface expression was increased at all time points of ischemia ([@B84]). In normal conditions, HCN1 subunit expression is more abundant than HCN2 in the hippocampal CA1 region. Therefore, the HCN1 subunit is more likely to form homologous channels. However, during the CCH process, due to the continuous increase of HCN2 subunits, the probability that HCN1 subunits will form heterologous channels with HCN2 subunits increases. Since the properties of homologous and heterologous channels differ, the hippocampal synaptic plasticity attributed to HCN channels is altered, which in turn leads to changes in spatial learning and memory. Thus, they proposed that in the early stages of CCH, the impairment of spatial motor memory in rats may be caused by common changes of HCN1 and HCN2, and later, the disorder was attributed to the upregulation of HCN2 expression. A similar phenomenon was also observed by [@B80] in the hippocampal CA1 area in rats after 5 weeks of 2VO, with reduced HCN1 expression and increased HCN2 expression. Moreover, [@B80] found that restoring the surface expression of HCN1 and HCN2 could ameliorate the impairment of spatial learning and memory. Together, these studies on learning and memory suggest novel avenues of research into the pathogenesis of AD ([Table 2](#T2){ref-type="table"}).

###### 

Roles of HCN channels in learning and memory of relevance to AD.

  Models                                         Main findings                                                                                                                                                                                                                                    References
  ---------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------
  HCN1^-/-^ mice                                 As *I*~h~ decreases, the resting membrane potential became hyperactivated and input resistance increased significantly, resulting in further enhancement of the amplitude and duration of distal dendritic Ca^2+^ events.                        [@B133]
  HCN1^-/-^ mice/HCN1*^f/f,cre^* mice            Theta activity was selectively enhanced in hippocampal CA1 pyramidal neurons.                                                                                                                                                                    [@B106]
  HCN1*^f/f,cre^* mice                           LTP was significantly enhanced at the direct perforant path input to the distal dendrites of CA1 pyramidal neurons, as was spatial learning and memory.                                                                                          [@B106]
  HCN2^-/-^ mice                                 LTP was significantly enhanced.                                                                                                                                                                                                                  [@B89]
  Mice with deletion of HCN2 from interneurons   LTP was significantly enhanced.                                                                                                                                                                                                                  [@B89]
  HCN3^-/-^ mice                                 There were no significant deficits in motor learning and spatial learning in comparison with control mice.                                                                                                                                       [@B128]
  2VO rats                                       Rats displayed a prolonged time to swim to the platform and altered expression patterns of HCN1 and HCN2 in the hippocampal CA1 area. Spatial learning and memory impairment could be improved when restoring the expression of HCN1 and HCN2.   [@B80]; [@B84]
                                                                                                                                                                                                                                                                                                  

HCN1

-/-

, HCN1 knockout; HCN1

f/f,cre

, forebrain-restricted knockout; HCN2

-/-

, HCN2 knockout; HCN3

-/-

, HCN3 knockout; LTP, long-term potentiation; 2VO, permanent bilateral occlusion of the common carotid arteries.

Role of HCN Channels in Other Neurodegenerative Diseases
========================================================

HCN Channels and ALS
--------------------

Amyotrophic lateral sclerosis is a universally fatal neurodegenerative disease characterized by progressive loss of corticospinal neurons, brainstem motor neurons, and spinal motor neurons, which leads to progressive weakness and paralysis. A recent study found that vesicle associated membrane protein B (VAPB), which modulates the surface expression and cellular localization of HCN1 and HCN2 channels, exhibited decreased expression in motor neurons of ALS8 patients, a typical form of familial ALS, as well as in the motor neurons of sporadic ALS patients ([@B2]; [@B94]; [@B123]). [@B123] reported that HCN2 and VAPB were co-localized in both HCN2-transfected HeLa cells and VAPB-transfected HeLa cells. However, this co-localization was not observed in HeLa cells transfected with the VAPB^P56S^ mutant ([@B123]). Indeed, HCN2 current amplitude was noticeably decreased by VAPB modulation. Mutation or loss of VAPB led to a decrease in HCN activity and neuronal excitability in motor neurons, which are a main cell type involved in the pathogenesis of ALS ([@B123]).

HCN Channels and SMA
--------------------

Spinal muscular atrophy is an autosomal recessive motor neuron disorder, characterized by progressive muscle weakness, especially in the torso and proximal limbs ([@B115]). Currently, only two studies have examined the correlation between HCN channels and SMA. Similarly, to ALS, a mutation in VAPB has also been identified in SMA patients ([@B104]), establishing a potential connection between HCN channels and SMA, as VAPB modulates HCN channels. Recently, a marked enhancement of *I*~h~ amplitude as well as HCN channel expression was observed in the spinal cord and sciatic nerves of SMA mice. Furthermore, treatment with ZD7288 appeared to reduce early mortality, improve motor function, and restore neuromuscular junction architecture in SMA mice ([@B78]). These results provide initial evidence that HCN channels may play a role in SMA pathophysiology and could be a novel target for SMA treatment.

Conclusion
==========

HCN channels are key regulators of neuronal excitability and network activity within the nervous system. Increasing evidence supports a model in which modifications in their physiological function contributes to the pathogenic mechanisms of several neurodegenerative diseases, implying that they may be a potential therapeutic target. This review, albeit simplistic, summarizes much of the research aimed at understanding the roles of HCN channels in animal models of PD, AD, and other neurodegenerative diseases, as well as in patients. To date, studies have reported reduced HCN1 expression in AD patients ([@B117]) as well as mutation or loss of VAPB, an HCN regulator protein in ALS ([@B2]; [@B94]) and SMA patients ([@B104]). However, gene variants/mutations in HCN channels or their regulatory proteins have not been identified in human patients with other neurodegenerative disorders. Presently, research concerning the role of HCN channels in neurodegenerative diseases is in its infancy, with a lack of probing for them as candidate genes. Interestingly, recent work has identified a mutation in the HCN2 gene, and augmentation of *I*~h~ in patients with genetic epilepsy with febrile seizures plus. This study provides evidence for the possible involvement of HCN channel mutations in familial forms of human epilepsy ([@B35]). Therefore, further research on the variations of HCN and their regulatory proteins may be an exciting area for future research, especially in patients with neurodegenerative diseases.
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2VO

:   permanent bilateral occlusion of the common carotid arteries

6-OHDA

:   6-hydroxydopamine

Aβ

:   β-amyloid peptide

AD

:   Alzheimer's disease

ALS

:   amyotrophic lateral sclerosis

APP

:   amyloid-β precursor protein

calbindin

:   calcium-binding protein

cAMP

:   cyclic adenosine monophosphate

CCH

:   chronic cerebral hypoperfusion

Cm

:   capacitance values

CMA

:   chronic mild unpredictable stress

CSDS

:   chronic social defeat stress

CUS

:   chronic unpredictable stress

DAT

:   dopamine transporter

EPSPs

:   excitatory post-synaptic potentials

FL-APP

:   full-length APP

GP

:   globus pallidus

GPe

:   external globus pallidus

GPi

:   interior globus pallidus

HCN channels

:   hyperpolarization-activated cyclic nucleotide-gated channels

HCN1^-/-^

:   HCN1 knockout

HCN1^f/f,cre^

:   forebrain-restricted knockout

HCN2^-/-^

:   HCN2 knockout

HCN3^-/-^

:   HCN3 knockout

IFNs

:   interferons

IL-1β

:   interleukin 1β

IPSPs

:   inhibitory post-synaptic potentials

K-ATP

:   ATP-sensitive potassium channels

LPS

:   lipopolysaccharide

LTP

:   long-term potentiation

MPP^+^

:   1-methyl-4-phenylpyridinium

MPTP

:   1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

PD

:   Parkinson's disease

Rm

:   membrane resistance

ROS

:   reactive oxygen species

SCRs

:   somatic calcium responses

sIPSC

:   spontaneous inhibitory postsynaptic potentials

SMA

:   spinal muscular atrophy

SNc

:   substantia nigra pars compacta

STN

:   subthalamic nucleus

TNF-α

:   tumor necrosis factor-α

TRIP8b

:   Rab8b-interacting protein

VAPB

:   vesicle-associated membrane protein B

VTA

:   ventral tegmental area

X11L

:   X11-like protein
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